FDA says Tecentriq won't lose its bladder cancer nod despite phase 3 failure, Roche reports

FDA says Tecentriq won't lose its bladder cancer nod despite phase 3 failure, Roche reports

Submitted by admin on September 12, 2017 - 10:00pm
Source: 
Fierce Pharma
News Tags: 
FDA
Tecentriq
Roche
bladder cancer
clinical trials
Headline: 
FDA says Tecentriq won't lose its bladder cancer nod despite phase 3 failure, Roche reports

Do Not Allow Advertisers to Use My Personal information